hepatitis C

Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tue, 01/28/14 - 11:17 am
Idenix
Pharma CEOs
Gilead Sciences
hepatitis C
Ron Renaud
At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt
Bloomberg
Tue, 01/28/14 - 08:37 am
Gilead Sciences
hepatitis C
drug pricing
Sovaldi
High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead
Seeking Alpha
Thu, 01/23/14 - 08:23 am
hepatitis C
Gilead Sciences
Bristol-Myers Squibb
Sovaldi
declatasvir
Gilead's Sovaldi Hep C Drug Launch Strong
TheStreet.com
Tue, 01/21/14 - 09:35 am
Gilead Sciences
Sovaldi
hepatitis C
Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill
Bloomberg
Tue, 01/14/14 - 09:15 am
hepatitis C
Gilead Sciences
Bristol-Myers Squibb
Sovaldi
declatasvir
Enanta Joins Big Leagues With Hepatitis C Drug
Investors.com
Wed, 01/8/14 - 08:07 am
Enanta
hepatitis C
AbbVie
ABT-450
protease inhibitors
Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling
TheStreet.com
Tue, 01/7/14 - 09:26 am
Gilead Sciences
hepatitis C
Sovaldi
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Seeking Alpha
Fri, 01/3/14 - 11:41 am
Gilead Sciences
hepatitis C
Merck
Sovaldi
Vertex
Gilead Sciences: Sovaldi to Boost Shares in 2014, Maxim Group Says
Barron's
Thu, 01/2/14 - 11:28 am
Sovaldi
hepatitis C
Gilead Sciences
Gilead Hepatitis C Pill Leads 27 New U.S. Drug Approvals
Bloomberg
Wed, 01/1/14 - 11:02 am
Gilead
hepatitis C
drug approvals
Sovaldi
Can Gilead's $1,000 Pill Eradicate Hepatitis C?
Forbes
Thu, 12/19/13 - 11:35 am
Gilead
hepatitis C
Sovaldi
ledipasvir
Why Enanta Pharmaceuticals Shares Sank Like a Stone
Motley Fool
Thu, 12/19/13 - 08:08 am
Enanta
Sovaldi
Gilead Sciences
hepatitis C
ABT-450
AbbVie
Gilead to seek okay for combo hepatitis C pill in Q1
Reuters
Wed, 12/18/13 - 10:15 am
hepatitis C
Gilead Sciences
Sovaldi
ledipasvir
Gilead Sciences' $1,000 Per Day Sovaldi Pills Ready to Launch
Motley Fool
Fri, 12/13/13 - 12:35 pm
Gilead Sciences
Sovaldi
drug launches
hepatitis C
What Is Johnson & Johnson's Opportunity In Hepatitis C Market?
Forbes
Wed, 12/11/13 - 09:01 am
JNJ
hepatitis C
Olysio
Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large
Forbes
Wed, 12/11/13 - 08:34 am
hepatitis C
drug pricing
Gilead Sciences
Express Scripts
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tue, 12/10/13 - 10:49 am
hepatitis C
Enanta Pharmaceuticals
ABT-450
AbbVie
The Numbers Backing Gilead's Best and Fastest Drug Launch in History
TheStreet.com
Mon, 12/9/13 - 08:48 am
Gilead Sciences
drug launches
Sovaldi
hepatitis C
Gilead Wins FDA Approval for Blockbuster Hepatitis C Pill
Bloomberg
Fri, 12/6/13 - 05:41 pm
sofosbuvir
FDA
Gilead Science
hepatitis C
Sovaldi
What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs
Seeking Alpha
Fri, 12/6/13 - 10:30 am
JNJ
Gilead Sciences
hepatitis C
sofosbuvir
Olysio
AbbVie
Bristol-Myers Squibb
Merck

Pages